Details of Drug

Details of Drug

 Drug General Information (ID: D1425)
  Drug Name
Romiplostim
  Drug Type Small molecule
  Disease Class 3B64: Thrombocytopenia; 2A83: Multiple myeloma; 2A37: Myelodysplastic syndrome
  Therapeutic Class Platelet-Stimulating Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C15H14N2O
  InChI 1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8-
  InChIKey WUWDLXZGHZSWQZ-WQLSENKSSA-N
  Canonical SMILES CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C
  External Link
Pubchem ID 5329098
CAS Number 194413-58-6
CHEBI ID 91083
TTD ID D01PZD

Drug-Drug Interaction Network
  Sunburst Graph
AM006  Pharmacodynamic additive effects
BM047  Additive thrombogenic effects
  Relation Graph
 Full list of drugs interacting with Romiplostim
      Pharmacodynamic additive effects
   Additive thrombogenic effects Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0261
 
Carfilzomib
 
C40H57N5O7
 
11556711 
Major    Inter Info   
[1], [2], [3]
References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Product Information. Kyprolis (carfilzomib). Onyx Pharmaceuticals Inc, South San Francisco, CA.
3 Cerner Multum, Inc. "UK Summary of Product Characteristics.".